GE Healthcare unveiled two recently FDA-cleared systems aimed at providing versatility and advanced imaging for interventional cardiology at the American College of Cardiology (ACC)’s 61st Annual Scientific Session & Expo, March 24-27 in Chicago.
Specifically, GE highlighted its recently FDA-cleared Discovery* IGS 730 system, the first interventional X-ray system designed to capture the advantages of both floor- and ceiling-mounted systems. Initially introduced last fall, the Discovery system was designed to address the trade-off departments have historically needed to make between ceiling- and floor-mounted systems, eliminating the need to compromise on patient access and image quality. The Discovery IGS 730 is a revolution in imaging. It is neither floor- nor ceiling-mounted, but enables full patient access without the need to suspend the system above the patient. It has the mobility of a C-arm with the power and image quality of a fixed system. This laser-guided, motorized mobile gantry creates an interventional environment without boundaries. It allows complete access to the patient and unlimited parking capability, while creating sterility for a flexible and secure OR environment. The unique gantry comes with a new wide bore design, which allows for steep angles, ease in 3D acquisition, especially for large patients.
GE will also introduce the FDA-approved Innova* IGS 520/530 with the OR option to expand the use of its Innova imaging system in the hybrid OR setting. Thanks to a specifically designed table and accessories, the Innova IGS 520/530 OR enables both transcatheter and open surgical procedures in the one room.
GE is also highlighting its Innova HeartVision solution to help support device localization and guidance during structural heart procedures, especially TAVR procedures. The HeartVision function fuses in real time 2D X-ray images and 3D models, such as the 3D cardiac model, from multiple modalities. It can be synchronized with ECG gating and can help compensate for patient heart and respiratory motion throughout the procedure for quality treatment. Innova HeartVision can reduce procedure time and dose, and increase physician confidence by providing the visual tools to make challenging interventions more accessible.
“Interventional cardiology procedures are becoming increasingly complex, and now may be performed in a variety of settings in the hospital, including the operating room. GE Healthcare is revolutionizing cardiac imaging with solutions that adapt to a wider array of environments,” said Reaz Rasul, General Manager, Interventional Cardiology, GE Healthcare - Detection & Guidance Solutions. “With the development of Discovery IGS 730 and Innova IGS 520/530 OR, we are arming physicians with solutions that combine cutting-edge imaging with greater versatility to meet more clinical needs.”
About GE Healthcare
GE Healthcare (gehealthcare.com) provides transformational medical technologies and services that are shaping a new age of patient care. Our broad expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, drug discovery, biopharmaceutical manufacturing technologies, performance improvement and performance solutions services help our customers to deliver better care to more people around the world at a lower cost. In addition, we partner with healthcare leaders, striving to leverage the global policy change necessary to implement a successful shift to sustainable healthcare systems.
Our “healthymagination” vision for the future invites the world to join us on our journey as we continuously develop innovations focused on reducing costs, increasing access and improving quality around the world. Headquartered in the United Kingdom, GE Healthcare is a unit of General Electric Company (NYSE: GE). Worldwide, GE Healthcare employees are committed to serving healthcare professionals and their patients in more than 100 countries.
For our latest news, please visit newsroom.gehealthcare.com/.